scholarly journals Faculty Opinions recommendation of Role of Perfusion-Weighted Imaging in a Diffusion-Weighted-Imaging-Negative Transient Ischemic Attack.

Author(s):  
Jose Biller ◽  
Michael Schneck
2017 ◽  
Vol 13 (2) ◽  
pp. 129 ◽  
Author(s):  
Sang Hun Lee ◽  
Hyun Wook Nah ◽  
Bum Joon Kim ◽  
Sung Ho Ahn ◽  
Jong S. Kim ◽  
...  

2019 ◽  
Vol 86 (3) ◽  
pp. 452-457 ◽  
Author(s):  
Benjamin Hotter ◽  
Ivana Galinovic ◽  
Claudia Kunze ◽  
Peter Brunecker ◽  
Gerhard J. Jungehulsing ◽  
...  

Stroke ◽  
2017 ◽  
Vol 48 (7) ◽  
pp. 1990-1992 ◽  
Author(s):  
Kenji Shono ◽  
Junichiro Satomi ◽  
Yoshiteru Tada ◽  
Yasuhisa Kanematsu ◽  
Nobuaki Yamamoto ◽  
...  

2016 ◽  
Vol 12 (3) ◽  
pp. 264-272 ◽  
Author(s):  
Leka Sivakumar ◽  
Parnian Riaz ◽  
Mahesh Kate ◽  
Thomas Jeerakathil ◽  
Christian Beaulieu ◽  
...  

Background Temporary and permanent cognitive changes following transient ischemic attack/minor stroke have been described previously. It is unknown if persisting cognitive deficits in these patients are correlated with acute infarction identified using magnetic resonance imaging. Aims We tested the hypothesis that persistent cognitive impairment after transient ischemic attack/minor stroke can be predicted by the volume of diffusion-weighted imaging lesions. Methods Acute transient ischemic attack/minor stroke (NIH stroke scale score ≤ 3) patients were prospectively recruited within 72 h of onset. Patients underwent Montreal cognitive assessment and magnetic resonance imaging, including diffusion-weighted imaging and Fluid-Attenuated Inverse Recovery sequences, at baseline, days 7 and 30. Cognitive testing was repeated at day 90. Diffusion-weighted imaging lesion and Fluid-Attenuated Inverse Recovery chronic white matter hyperintensity volumes were measured planimetrically. Cognitive impairment was defined a priori as Montreal cognitive assessment score < 26. Results One hundred fifteen patients were imaged at a median (inter-quartile range) of 24.0 (16.6) h after onset. Acute ischemic lesions were present in 91 (79%) patients. Cognitive impairment rates were similar in patients with (47/91, 52%) and without diffusion-weighted imaging lesions (13/24, 54%; p = 0.83). Although linear regression indicated no relationship between acute diffusion-weighted imaging lesion volume and day 30 Montreal cognitive assessment scores (β = −0.163, [−2.243, 0.334], p = 0.144), white matter hyperintensity volumes at baseline were predictive of persistent cognitive deficits after 30 days (β = 2.24, [1.956, 45.369], p = 0.005). Conclusions In most transient ischemic attack/minor stroke patients who suffer acute cognitive impairment post event, deficits are temporary. Deficits after 30 days of onset are correlated with chronic white matter hyperintensity, suggesting subclinical cognitive impairment and/or impaired ability to compensate for the effects of acute ischemic infarcts.


2005 ◽  
Vol 19 (6) ◽  
pp. 362-368 ◽  
Author(s):  
Yuichiro Inatomi ◽  
Kazumi Kimura ◽  
Toshiro Yonehara ◽  
Shodo Fujioka ◽  
Makoto Uchino

Stroke ◽  
2004 ◽  
Vol 35 (10) ◽  
pp. 2313-2319 ◽  
Author(s):  
Francisco Purroy ◽  
Joan Montaner ◽  
Álex Rovira ◽  
Pilar Delgado ◽  
Manuel Quintana ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Lu-lu Pei ◽  
Pei Chen ◽  
Hui Fang ◽  
Yuan Cao ◽  
Yi-nan Guo ◽  
...  

Abstract Dual antiplatelet therapy (DAPT) reduced stroke risk in high-risk transient ischemic attack (TIA) patients assessed by ABCD2 score. Patients with positive diffusion-weighted imaging (DWI) were identified as imaging-based high-risk. The present study aims to investigate whether DAPT could reduce stroke risk in TIA with DWI positive. The study enrolled TIA patients within 72 h of onset from the prospective TIA database of the First Affiliated Hospital of Zhengzhou University. The predictive outcome was ischemic stroke at 90-day. The relationship between DAPT and stroke was analyzed in a cox proportional hazards model. The Kaplan–Meier curves of TIA patients with DAPT and monotherapy were plotted. Total of 661 TIA patients were enrolled, 279 of whom were DWI positive and 281 used DAPT. The 90-day stroke risk was higher in patients used monotherapy than those used DAPT in TIA with positive DWI (23.7% vs. 13.4%, p = 0.029). DAPT was associated with reduced stroke risk in TIA patients with positive DWI (hazard ratio [HR] = 0.54; 95% confidence interval [CI], 0.30–0.97; p = 0.037). However, the benefit didn’t exist in TIA patients with negative DWI (HR = 0.43; 95% CI, 0.14–1.33; p = 0.142). Early use of DAPT reduced stroke risk in TIA patients with positive DWI.


Sign in / Sign up

Export Citation Format

Share Document